TERUMO CORPORATION
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Terumo Establishes Corporate Venture Capital "Terumo Ventures" 2024-08-06 09:00
FDA Clears the Individualized Nomogram for Rika Plasma Donation System 2024-05-09 20:00
Terumo Blood and Cell Technologies' Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use 2023-08-01 20:30
Terumo Blood and Cell Technologies' IMUGARD Platelet Pooling Set Cleared by FDA 2023-02-17 03:48
New Randomized Controlled Study Published in JAMA Demonstrates the Value of Clinical Decision Support Tools in Preventing Acute Kidney Injury in Patients Undergoing Coronary Angiography 2022-11-01 20:00
Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan 2022-05-16 15:19
Terumo and Glooko Announce Collaboration on New Solution for Diabetes Data Sharing 2022-03-30 15:00
Terumo Establishes Group-wide 'DE&I Philosophy' to Further Cultivate a Diverse, Equitable and Inclusive Culture 2022-03-01 09:00
Terumo and Corazon Sign Collaboration and Co-Marketing Agreement 2022-02-25 22:00
Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A 2022-01-12 03:40
Terumo Corporation and Diabeloop SA. Enter into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offerings 2021-11-17 16:00
Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe 2021-11-17 00:00
Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare 2021-09-17 15:30
Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy 2021-08-11 23:00
Terumo and UMCU strengthen their partnership to develop solutions in Interventional Oncology 2021-07-20 22:54
Terumo Introduces New AZUR™ Vascular Plug and PG Pro™ Peripheral Microcatheter Embolization System 2021-07-14 20:00
Terumo Donates Additional USD 1 Million to Support the COVID-19 Solidarity Response Fund for WHO 2021-05-14 09:05
Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform 2021-04-20 05:00
Terumo is building a Global Therapeutic Interventional Oncology team to offer more therapeutic solution to cancer patients 2021-04-12 22:25
Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc. 2021-02-24 07:00
1 2